City-Wide Palliative/Ethics Grand Rounds - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

City-Wide Palliative/Ethics Grand Rounds

Description:

City-Wide Palliative/Ethics Grand Rounds Next Session 11/19/07 Barry Smith SUNY Distinguished Professor Julian Park Professor The Future of Biomedical Informatics – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0
Slides: 43
Provided by: Jack1186
Category:

less

Transcript and Presenter's Notes

Title: City-Wide Palliative/Ethics Grand Rounds


1
City-Wide Palliative/Ethics Grand Rounds
  • Next Session 11/19/07
  • Barry Smith
  • SUNY Distinguished Professor
  • Julian Park Professor
  • The Future of Biomedical Informatics

2
Jack P. Freer, MD
  • UB
  • Professor of Clinical Medicine
  • Palliative Medicine Course Coordinator
  • Kaleida Health
  • Ethics Committee Chair
  • Palliative Care Consultation (Gates)

3
CME Disclosure
  • No commercial support
  • No unapproved or off-label uses

4
Breathlessness
  • Jack P. Freer, MD
  • Professor of Clinical Medicine
  • University at Buffalo

5
Learning Objectives
  • Understand pathophysiology of dyspnea
  • Be familiar with basic modalities of treatment
  • Be capable of sound ethical reasoning in
    intubation/ventilation decisions
  • Be able to guide coherent decisions based upon
    good medicine and good ethics

6
Dyspnea
  • Pathophysiology
  • Treatment
  • Decision Making/Ethical Issues

7
Dyspnea shortness of breath, breathlessness
  • Rapid breathing
  • Incomplete exhalation
  • Shallow breathing
  • Increased work/effort
  • Feeling of suffocation
  • Air hunger
  • Chest tightness
  • Heavy breathing

8
Dyspnea shortness of breath, breathlessness
  • Rapid breathing
  • Incomplete exhalation
  • Shallow breathing
  • Increased work/effort
  • Feeling of suffocation
  • Air hunger
  • Chest tightness
  • Heavy breathing
  • COPD, pulm vasc dis
  • Asthma,
  • Asthma, Neuro-musc, Chest wall
  • COPD, Interstitial, Asthma, N-m, Cw
  • COPD, CHF
  • COPD, CHF, Pregnancy
  • Asthma
  • Asthma
  • Manning HL, Schwartzstein RM Pathophysiology of
    Dyspnea. NEJM (1995), 3331547-1553

9
Dyspnea
  • Cancer (dyspnea common)
  • Obvious cause (lung mets, effusion etc)
  • Co-morbid conditions (COPD/CHF)
  • No evidence of 1. or 2. (?cachexia)
  • Non-malignant (COPD, CHF)

10
Dyspnea in Cancer
  • Cancer related causes
  • Treatment related causes
  • General medical condition causes

11
Cancer Related Causes
  • Airway obstruction by tumor
  • Lung parenchyma replacement
  • Pleuro-pericardial effusion
  • Lymphangitic carcinomatosis
  • SVC syndrome
  • Ascites

12
Treatment Related Causes
  • Pneumonectomy
  • Radiation fibrosis
  • Chemotherapy
  • Cardiac toxicity
  • Pulmonary toxicity

13
General Medical Conditions(both related and
unrelated to cancer)
  • COPD
  • CHF
  • Asthma
  • Infection
  • Anemia
  • Pneumothorax
  • Pulmonary embolus Pulmonary hypertension
  • Psychosocial/Spiritual

14
Mechanism of Dyspnea
  • Mechanical Receptors
  • Lung
  • Chest wall
  • Upper airway

15
Mechanism of Dyspnea
  • Sense of Respiratory Effort
  • Effort major factor in breathlessness
  • Simultaneous motor cortex signals
  • Efferent to respiratory muscles
  • Signal to sensory cortex

16
Manning HL, Schwartzstein RM Pathophysiology of
Dyspnea. NEJM (1995), 3331547-1553
17
Mechanism of Dyspnea
  • Sense of Respiratory Effort
  • Effort major factor in breathlessness
  • Simultaneous motor cortex signals
  • Efferent to respiratory muscles
  • Signal to sensory cortex
  • Mismatch enhances sense of effort
  • Probably similar signals from brainstem

18
Mechanism of Dyspnea
  • Chemical Receptors
  • Hypercapnia
  • Hypoxia

19
Mechanism of Dyspnea
  • Hypercapnia
  • Early studies in normal subjects suggested CO2
    not a factor
  • Probably mediated by pH

20
Mechanism of Dyspnea
  • Hypoxia
  • Some evidence of effect
  • Still
  • Some patient hypoxicnot SOB
  • Some patients SOBnot hypoxic
  • Some hypoxic/SOB pts show little improvement with
    O2 therapy

21
Treatment of Dyspnea
  • Treat underlying causes
  • Oxygen
  • Nebulized bronchodilators
  • Opioids
  • Benzodiazepines
  • Nebulized opioids used by some but no solid
    evidence of efficacy
  • Fans across face

22
(No Transcript)
23
Decision Making/Ethical Issues
  • Opioids and hastening death
  • Withdraw vs. Withhold
  • DNI

24
Resistance to Opioids for Dyspnea
  • Hasten death kill patient
  • Response
  • Tolerance to respiratory depression
  • Slowing respirations may improve oxygenation

25
Resistance to Opioids for Dyspnea
  • However, failing to intubate and ventilate a
    patient in severe respiratory failure will result
    in death (with or without opioids).
  • Opioids may hasten that death
  • Double effect

26
Withhold LST vs. Withdraw
  • Logical/clinical difference?
  • Therapeutic trials
  • Duty to start or stop independent of whether the
    treatment is already in place
  • Legal difference? NO
  • Religious difference
  • Psychological difference

27
Withhold vs. Withdraw Ventilator
  • Quality of life (prior to vent decision)
  • Reversibility

28
Withhold vs. Withdraw Ventilator
  • Trialwithdraw later
  • Acceptable quality of life
  • Reversible condition

29
Withhold vs. Withdraw Ventilator
  • Trialwithdraw later
  • Acceptable quality of life
  • Reversible condition
  • Clear timetable, endpoints to gauge success of
    the trial

30
Withhold vs. Withdraw Ventilator
  • Trialwithdraw later
  • Acceptable quality of life
  • Reversible condition
  • Clear timetable, endpoints to gauge success of
    the trial
  • Legally appointed agent to act on behalf of the
    patient

31
Withhold vs. Withdraw Ventilator
  • Die without intubation/ventilation (DNI)
  • Poor quality of life
  • Irreversible process

32
Withhold vs. Withdraw Ventilator
  • Die without intubation/ventilation (DNI)
  • Poor quality of life
  • Irreversible process
  • Prior reversible process, tough wean

33
Withhold vs. Withdraw Ventilator
  • Die without intubation/ventilation (DNI)
  • Poor quality of life
  • Irreversible process
  • Prior reversible process, tough wean
  • Crystal clear informed consent NO need for last
    minute clarification.

34
Withhold vs. Withdraw Ventilator
  • Die without intubation/ventilation (DNI)
  • Poor quality of life
  • Irreversible process
  • Prior reversible process, tough wean
  • Crystal clear informed consent NO need for last
    minute clarification.
  • Scrupulous symptom management

35
Withhold vs. Withdraw Ventilator
  • Trial / Withdraw
  • Good QoL
  • Reversible
  • ________________
  • Clear Endpoints
  • Timeframe
  • Outcomes
  • Proxy
  • Withhold
  • Poor QoL
  • Irreversible
  • ________________
  • Clear Consent
  • No last minute clarifications
  • Symptom Treatment

36
Dying Without Intubation
  • Decision making
  • Broad planning based on goals of treatment
  • Positive treatment directed toward ALL goals
  • Reversibility/Quality of life
  • Treat respiratory failure symptomatically
  • No intubation/ventilation

37
Dying Without Intubation
  • Documentation
  • Document rationale in detail
  • Document informed consent discussion
  • Detailed symptomatic plan
  • Communication
  • Clear discussions with nurses, family
  • Explain what to expect
  • Avoid focus on not

38
Dying Without Intubation
  • What if the patient changes his mind?

39
Dying Without Intubation
  • Failure to document the informed consent
    discussion can lead to last minute
    clarification about decision (and patient
    changing mind about intubation).

40
Dying Without Intubation
  • Failure to provide adequate symptom relief can
    lead to suffering (and patient changing mind
    about intubation).

41
Respiratory Death without Intubation/Ventilation
  • can be the most appropriate and ethically
    defensible option.
  • can be part of a comprehensive palliative plan
    based on the patients goals of care.
  • can NOT be summarized in 3 letters.

42
Editorial
Write a Comment
User Comments (0)
About PowerShow.com